Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02327845 · ClinicalTrials.gov registry record
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
A clinical trial, sponsored by University of Miami.
- Active
- Registry status
- 708
- Enrollment target
NCT02327845: Active study, sponsored by University of Miami.
NCT02327845 is a clinical trial that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 708 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02327845 is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- 708 participants
- Enrollment target
Study Summary
The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotemporal dementia (FTD); and (2) to develop biomarkers that might be useful in aiding therapy development for this group of disorders.
Primary Outcome
Using longitudinally collected deep phenotypic data, this project aims to define the natural history (i.e. temporal rate of disease progression) of the motor and frontotemporal system (behavior, cognition and language) phenotypes of ALS and related disorders in patients with identifiable genetic mutations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 708 participants |
| Start Date | 2015-04 |
| Est. Completion | 2031-08 |
What the registry record for NCT02327845 still lists
NCT02327845 is an observational study that tracks outcomes without assigning an intervention. The registered 708 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02327845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02327845 about?
NCT02327845 is a clinical study titled "Phenotype, Genotype & Biomarkers in ALS and Related Disorders". The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotempora...
What is the current status of trial NCT02327845?
This trial is currently active not recruiting. The enrollment target is 708 participants. The study started on 2015-04. Estimated completion is 2031-08.
Who is sponsoring clinical trial NCT02327845?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia